Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 34 of 138 for:    (domestic or partner) AND (violence OR abuse)

The Development of a Domestic Violence Perpetrator Collusion Measurement Tool

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01942616
Recruitment Status : Completed
First Posted : September 16, 2013
Last Update Posted : September 16, 2013
Sponsor:
Information provided by (Responsible Party):
Yale University

Brief Summary:
We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration.

Condition or disease Intervention/treatment Phase
Intimate Partner Violence (IPV) Other: Condition 1: Perpetrator Positive Other: Condition 2: Perpetrator Negative Other: Condition 3: Placebo Not Applicable

Detailed Description:

Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.

Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.

Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.

Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.

Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.

Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Screening
Official Title: Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.
Study Start Date : July 2009
Actual Primary Completion Date : January 2010
Actual Study Completion Date : January 2010

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Condition 1

Each study arm contains different scenarios presented to the participant.

Condition 1 is a Perpetrator Positive scenario.

The content of the Condition 1 group is as follows:

Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim

Other: Condition 1: Perpetrator Positive
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.

Experimental: Condition 2

Each study arm contains different scenarios presented to the participant.

Condition 2 is a Perpetrator Negative scenario.

The content of the Condition 2 group is as follows:

Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator

Other: Condition 2: Perpetrator Negative
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.

Placebo Comparator: Condition 3

Each study arm contains different scenarios presented to the participant.

The content of the Condition 3 group is as follows:

Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None

Other: Condition 3: Placebo
This intervention provides no details for the participant and is for comparison use in the study.




Primary Outcome Measures :
  1. Change from Baseline on The Collusion Framing Subscale [ Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart. ]
    The scale will be developed based on the changes from baseline.

  2. Change from Baseline on The Collusion Labeling Subscale [ Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart. ]
    The scale will be developed based on the changes from baseline.

  3. Change from Baseline on The Collusion Extraneous Information Subscale [ Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart. ]
    The scale will be developed based on the changes from baseline.

  4. Change from Baseline on The Collusion Negative Characteristics Subscale [ Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart. ]
    The scale will be developed based on the changes from baseline.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Members of the public who are 18 years or older, who identify as White or African American or Hispanic.

Exclusion Criteria:

  • Members of the public will be excluded if they are unable to read or understand English.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01942616


Locations
Layout table for location information
United States, Connecticut
Yale University
New Haven, Connecticut, United States, 06519
United States, Louisiana
Loyola University New Orleans
New Orleans, Louisiana, United States, 70118
United States, Michigan
Michigan State University
East Lansing, Michigan, United States, 48824
Michigan Department of Community Health
Lansing, Michigan, United States, 48913
Sponsors and Collaborators
Yale University

Layout table for additonal information
Responsible Party: Yale University
ClinicalTrials.gov Identifier: NCT01942616     History of Changes
Other Study ID Numbers: 0910005885
First Posted: September 16, 2013    Key Record Dates
Last Update Posted: September 16, 2013
Last Verified: September 2013

Keywords provided by Yale University:
IPV